DocDollars

Phathom Pharmaceuticals, Inc.

NJ · United States · Reporting entity ID 100001176938

Total reported 2019–2025
$17.2M
#356 of 2,960 reporting companies — 0% of all reported industry payments
$16.0M in general payments across 186,517 records, plus $1.25M in research funding across 241 records.

How it breaks down

General payments $15,976,564
Research funding $1,251,705

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Phathom Pharmaceuticals, Inc. reported $17.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #356 of 2,960 reporting companies. 7% of that was research funding and 93% general payments such as consulting, speaking, food and travel. 186,517 general payment records and 241 research records were filed.

Common questions about Phathom Pharmaceuticals, Inc.

How much has Phathom Pharmaceuticals, Inc. paid US doctors?

Phathom Pharmaceuticals, Inc. reported $17,228,269 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $15,976,564 in general payments, $1,251,705 in research funding.

How does Phathom Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #356 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Phathom Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.